Phase 4, Open-Label Study

34 adult patients participated in a Phase 4, open-label study for mild to severe plaque psoriasis in intertriginous areas.23,24

View Study Design

In intertriginous areas, VTAMA cream demonstrated rapid and powerful efficacy23

VTAMA cream Efficacy Results at week 1223

82.8% of adult patients (n=29) achieved an iPGA score of 0 (clear) or 1 (almost clear) and at least a 2-grade improvement from baseline at week 12 with a median time of ~6 weeks23

65.5% of adult patients achieved an iPGA score of 0 (clear), which indicates complete clearance at week 12, with a median time of ~8 weeks, with some patients achieving it as early as 2 weeks23

75% of adult patients achieved itch relief with ≥4-point improvement in PP-NRS at week 12 (intertriginous areas)24

Patients Achieving a ≥4-point Improvement in PP-NRS by Visit (ITT, OC)*24

*Patients with baseline PP-NRS score of ≥4 who achieved ≥4-point improvement in the PP-NRS from baseline.